Session: Integrated API and Drug Product Development

This session will focus on the interaction between active pharmaceutical ingredient (API) properties and the properties of the final product required to achieve pharmaceutical benefit. We invite submissions on topics including but not limited to: API - excipient interactions, enhancement of API solubility, API surface, morphology or particle size effects, impact of API variability on its delivery, extended release delivery systems, processing strategies for property optimization.